Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …

Background: Prostate cancer (PCa) patients initiating androgen deprivation therapy (ADT)
are suffering from adverse effects; exercise has been proposed as a treatment to relieve …

Clear cell renal cell carcinoma (ccRCC) is fundamentally a metabolic disease. Given the
importance of lipids in many cellular processes, in this study we delineated a lipidomic …

Background: Several biochemical and clinical markers have been proposed for selecting
patients for active surveillance (AS). However, some of these are expensive and not easily …

Simple Summary Recently, biomarkers have become a supplemental tool to aid in the
diagnosis and evaluation of prostate cancer. Numerous biomarkers are being developed …

Background: Since prostate-specific antigen (PSA) levels can be influenced by some
routinely available clinical factors, a retrospective study was conducted to explore the …

Abstract Background: Prostate cancer (PCa) represents one of the most frequent
malignancies and the fifth leading cause of cancer death in adult men worldwide. PCa …

Purpose The association between circulating total testosterone (T) levels and clinically
significant PCa is still a matter of debate. In this study, we evaluated whether serum …

Carcinogenesis is frequently linked to genetic background, however, exposure to
environmental risk factors has gained attention as the etiologic agent for several types of …

The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is
increasing every year; however, the literature shows that many men are using testosterone …